Development of a Road Map to Controlled Substance Diversion Prevention
|
|
- Bernard Hines
- 5 years ago
- Views:
Transcription
1 Development of a Road Map to Controlled Substance Diversion Prevention Rene Cronquist, RN, J.D. Director of Practice and Policy Minnesota Board of Nursing
2 In the news. Prison Sought for Nurse Who Stole Drugs Nurse Accused of Stealing Patient s Prescription Nurse Pleads Guilty to Stealing Narcotics from Patients
3 Concerns Patient safety Patients deprived of necessary pain medications Potential for overmedication if subsequent doses are adjusted based on lack of pain relief Infection (contaminated IV meds) Nurse impairment while on duty Fear, reluctance to trust nurses Cost
4 Beyond the headlines Controlled substance diversion is a problem that concerns a number of parties. Each party had been addressing the problem from their point of view, with little coordination among the parties.
5 How to build a better mousetrap May 2011 the Minnesota Department of Health and the Minnesota Hospital Association assembled a coalition of stakeholders to address controlled substance diversion. Many of the parties that ultimately became involved in this project had a history of working together on other patient safety issues through the Minnesota Alliance of Patient Safety (MAPS).
6 The Coalition Participants included representatives from: Associations of health care organizations Infection Control County attorney Law enforcement local, DEA and FDA Large health systems Retail pharmacy & health system pharmacists Health Boards (Nursing, Medicine, Pharmacy) Boards alternative monitoring program (HPSP)
7 Narrowing the Universe The Coalition quickly realized the problem of drug diversion is vast and multifaceted. To be timely and effective, the group decided to be clear and concise about its focus. The focus became controlled substance diversion (as opposed to all drugs that might be diverted) and the acute care setting (hospitals).
8 Objectives Identify best practices and resources to prevent and increase awareness of diversion. Guidance to parties on how, when and with whom information may, can and/or must be shared. Recommend measures to quantify cases of diversion. Disseminate information to health care providers and organizations and the public.
9 How to accomplish the work Work groups Best practices/resources for prevention, awareness and detection of diversion Communication across coalition organizations and investigative organizations State and Federal reporting obligations Dissemination of resource materials Identification of measurements to gauge scope of the issue and impact of the coalition work
10 Prevention Roadmap Outline SAFE infrastructure Best Practices Principles Tool Kit
11 SAFE S: Safety teams/organizational structure A: Access to information F: Facility expectations E: Educate staff and patients
12 SAFE infrastructure Organization defines, and the structure supports, an effective CS diversion prevention program Proactive collaboration with law enforcement Commitment to collection, auditing and review of relevant data Organization sets and communicates expectation that staff speak up when a potential diversion concern is identified HR practices support organization-wide diversion program
13 Best Practices Procurement Storage and security Prescribing Preparation and dispensing Administration of CS Handling wastage Follow-up if diversion is suspected
14 Tools in the Tool Kit Includes: State and Federal laws and rules Diversion Prevention Coordinator position description Internal investigation checklists Diversion investigation agencies Diversion reporting obligation flow sheet Articles and websites regarding substance abuse and identifying the impaired practitioner
15 Diversion Investigation Teams Recommendation for a team to respond to any irregularity in controlled substances. Team assists with determining what investigation is appropriate and coordinates or assists with coordination of investigation. Examples: Code N or Drug Diversion Investigations Resource Team (D DIRT) Includes reporting to external agencies (e.g. law enforcement and Boards)
16 Outcomes of the Process Very beneficial to have the wide array of participants. In addition to identifying best practices, the coalition members developed helpful connections with other members. Better understanding of the roles, perspectives and challenges of each party. (Knowing who to call about what and when) Greater buy-in More outlets for dissemination of information
17 Disseminate information Encourage adoption of best practices Continued communication among coalition members Measure effectiveness Develop tools for other healthcare settings Next steps
18 Report, Roadmap and Toolkit The Minnesota Hospital Association - Controlled Substance Diversion Toolkit All of the above will soon be posted on Board s website:
Patient Safety. Road Map to Controlled Substance Diversion Prevention
Patient Safety Road Map to Controlled Substance Diversion Prevention Road Map to Diversion Prevention safe S Safety Teams/ Organizational Structure A Access to information/ Accurate Reporting/ Monitoring/
More informationPRESCRIBING IN NEVADA
PRESCRIBING IN NEVADA An Inside Look at Changes to Nevada Laws Surrounding Prescribing Controlled Substances for the Treatment of Pain These changes to Nevada law do not impact the authority of practitioners
More informationPlease adjust your computer volume to a comfortable listening level. This is lesson 4 How do you handle medication at home?
Welcome to the Pennsylvania Department of Public Welfare (DPW), Office of Developmental Programs (ODP) Medication Administration Course for life sharers. This course was developed by the ODP Office of
More informationUnderstanding Diversion in the Pharmacy Kimberly S. New JD BSN RN
Understanding Diversion in the Pharmacy Kimberly S. New JD BSN RN All Rights Reserved Scope of the Problem Diversion can t be prevented entirely Substantial safety, quality, regulatory and legal risk Mitigate
More informationPharmaceutical Diversion Prevention, Detection and Incident Response
Pharmaceutical Diversion Prevention, Detection and Incident Response HIPAA Security Officer, Mount Sinai Health System President, Society of Professional Investigators Associate Director of Administration
More information(b) Service consultation. The facility must employ or obtain the services of a licensed pharmacist who-
420-5-10-.16 Pharmacy Services. (1) The facility must provide routine and emergency drugs and biologicals to its residents, or obtain them under an agreement described in 483.75(h) of Title 42 Code of
More informationGENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 S 2 SENATE BILL 750* Health Care Committee Substitute Adopted 6/12/18
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 0 S SENATE BILL 0* Health Care Committee Substitute Adopted /1/ Short Title: Health-Local Confinement/Vet. Controlled Sub. (Public) Sponsors: Referred to: May,
More informationMedication Diversion and Prescription Drug Abuse in the Long Term Care Setting. Objectives
Medication Diversion and Prescription Drug Abuse in the Long Term Care Setting Objectives Discuss: Learn about signs of potential diversion and recognize an impaired healthcare provider. Help to identify
More informationLegal Issues in Managing Opioid Abuse. Gwen Dayton, JD
Legal Issues in Managing Opioid Abuse Gwen Dayton, JD Faculty Disclosure It is the policy of the Oregon Hospice Association to insure balance, independence, objectivity, and scientific rigor in all its
More informationDrug Diversion Prevention The Mayo Clinic Experience
Drug Diversion Prevention The Mayo Clinic Experience Kevin R. Dillon, Pharm.D., MPH Director of Pharmacy Services Mayo Clinic Health Care Compliance Association Upper Midwest - Regional Annual Conference
More informationNEW JERSEY. Downloaded January 2011
NEW JERSEY Downloaded January 2011 SUBCHAPTER 29. MANDATORY PHARMACY 8:39 29.1 Mandatory pharmacy organization (a) A facility shall have a consultant pharmacist and either a provider pharmacist or, if
More informationAHLA. T. Diversion of Controlled Substance in Health Care Setting
AHLA T. Diversion of Controlled Substance in Health Care Setting Lorri Hall Abramowitz Drug Diversion Specialist UF Health Jacksonville Jacksonville, FL Ann M. Bittinger The Bittinger Law Firm Jacksonville,
More informationLOUISIANA. Downloaded January 2011
LOUISIANA Downloaded January 2011 SUBCHAPTER A. PHYSICIAN SERVICES 9807. Standing Orders A. Physician's standing orders are permissible but shall be individualized, taking into consideration such things
More informationA Million Little Pieces: Developing a Controlled Substance Diversion Program. Tanya Y. Barnhart, PharmD, BCPS
A Million Little Pieces: Developing a Controlled Substance Diversion Program Tanya Y. Barnhart, PharmD, BCPS I have no conflicts of interest to disclose Objectives Explain the importance of building a
More informationEffectively Managing and Monitoring Controlled Substances in Research
Effectively Managing and Monitoring Controlled Substances in Research Emmelyn Kim, MA, MPH, CCRA, CHRC AVP, Research Compliance & Privacy Officer Ji Eun Kim, PhD, RPh Research Pharmacist The Office of
More informationTopics 5/16/2017. Effectively Managing and Monitoring Controlled Substances in Research
Effectively Managing and Monitoring Controlled Substances in Research Emmelyn Kim, MA, MPH, CCRA, CHRC AVP, Research Compliance & Privacy Officer Ji Eun Kim, PhD, RPh Research Pharmacist The Office of
More informationAdvancing MN Pharmacy 2016 Advocacy Accomplishments & 2017 Plans
Advancing MN Pharmacy 2016 Advocacy Accomplishments & 2017 Plans Jill Strykowski and Michelle Aytay MPhA Public Affairs Co Chairs, PPAJTF Session Objectives Outline the outcomes from the 2016 Legislative
More informationPHARMACEUTICALS AND MEDICATIONS
DESCHUTES COUNTY ADULT JAIL CD-10-17 L. Shane Nelson, Sheriff Jail Operations Approved by: December 6, 2017 POLICY. PHARMACEUTICALS AND MEDICATIONS It is the policy of Deschutes County Sheriff s Office
More information10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure
Controlled Substances Dispensing Issues and Solutions Ronald W. Buzzeo, R.Ph. Chief Compliance Officer November 7, 2012 CE Code: Financial Disclosure I have no actual or potentially relevant financial
More informationGuidance on the Delivery of Medicines Dispensed on Foot of a Prescription from a Retail Pharmacy Business
Guidance on the Delivery of Medicines Dispensed on Foot of a Prescription from a Retail Pharmacy Business Pharmaceutical Society of Ireland Version 1 July 2014 Contents 1. Introduction 2 2. Guidance 3
More informationBEST PRACTICES: DOCUMENTATION OF CLINICAL RATIONALE FOR CHRONIC OPIOID THERAPY THE LEGAL PERSPECTIVE PART I. The presentation was created by
BEST PRACTICES: DOCUMENTATION OF CLINICAL RATIONALE FOR CHRONIC OPIOID THERAPY THE LEGAL PERSPECTIVE PART I Jennifer Bolen, JD Former Federal Prosecutor Founder, the Legal Side of Pain Presented August
More informationCONSULTANT PHARMACIST INSPECTION LAW REVIEW
CONSULTANT PHARMACIST LAW REVIEW Florida Consultant Pharmacist s are required in: a. Class I Institutional Pharmacies b. Class II Institutional Pharmacies c. Modified Class II Institutional Pharm. d. Assisted
More informationOPINION: Pharmeceutical Processes APPROVED DATE: October 2018 REVIEWED DATE: REVISED DATE: ORIGINATING COMMITTEE: Practice Committee
Wyoming State Board of Nursing 130 Hobbs Avenue, Suite B Cheyenne, WY 82002 Phone (307) 777-7601 Fax (307) 777-3519 E-Mail: wsbn-info-licensing@wyo.gov Home Page: https://nursing-online.state.wy.us/ OPINION:
More informationData Analytics In Healthcare Diversion Prevention, Detection and Response Quality Improvement
Data Analytics In Healthcare Diversion Prevention, Detection and Response Quality Improvement This presentation will cover The Wake-up call How we incorporated data analytics into our diversion detection
More informationHB 1 Regulations Board of Medical Licensure
HB 1 Regulations Board of Medical Licensure C. Lloyd Vest II, J.D. General Counsel Kentucky Board of Medical Licensure Faculty Disclosure I have not had any relevant financial relationships during the
More informationSession 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER
Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Disclosure The Immunization Action Coalition has been responsible for all aspects of content development for the enclosed presentation
More informationMedication Management and Diversion Control
Medication Management and Diversion Control Karla M Miller, Pharm D July 2017 January 18, 2017 NEWS Surgery Center Director Removed from Position after Alleged Drug Theft Director of the surgery center
More informationPolicies Approved by the 2017 ASHP House of Delegates
House of Delegates Policies Approved by the 2017 ASHP House of Delegates 1701 Ensuring Patient Safety and Data Integrity During Cyber-attacks Source: Council on Pharmacy Management To advocate that healthcare
More informationDrug Diversion. New Jersey s Drug Diversion Pilot Project Exercise
Drug Diversion New Jersey s Drug Diversion Pilot Project Exercise What is Drug Diversion? When prescription medicines are obtained or used illegally Illegal distribution or abuse of prescription drugs
More informationMINNESOTA BOARD OF PHARMACY
MINNESOTA BOARD OF PHARMACY Prescription Drug Waste Reduction Report. (In compliance with Minnesota Session Laws, 2010 First Special Session, Chapter 1, section 21) Cody Wiberg, Pharm.D., M.S., R.Ph. Executive
More informationAMENDMENT TO SENATE BILL 772. AMENDMENT NO.. Amend Senate Bill 772, AS AMENDED, by. replacing everything after the enacting clause with the following:
*LRB00RLC00a* Rep. Cynthia Soto Filed: //0 000SB0ham00 LRB0 0 RLC 00 a AMENDMENT TO SENATE BILL AMENDMENT NO.. Amend Senate Bill, AS AMENDED, by replacing everything after the enacting clause with the
More information7.200 DONATION OF UNUSED MEDICATIONS, MEDICAL DEVICES AND MEDICAL SUPPLIES
RQ Draft: 0 0 0 0 0 Proposed Regulation: DONATION OF UNUSED MEDICATION, MEDICAL DEVICES AND MEDICAL SUPPLIES The language proposed below would be added to CCR 0-, Chapter II - General Licensure Standards
More informationa remote pharmacy is not necessarily intended to provide permanent??? how do we make it so that it may be only for limited duration.
Board of Pharmacy Administrative Rules Version 12 January 18, 2013 Part 19 Remote Pharmacies 19.1 General Purpose: (a) This Part is enacted pursuant to 26 V.S.A. 2032 which initially authorized the Board
More informationSECTION 1: PROCESS FOR NEW/ANNUAL RENEWAL OF MED AGREEMENT:
Clinic Name Medication Agreement Process Effective Version #: Document #: Next Review: Page 1 of 8 SCOPE: Medication Agreement Process PURPOSE: Define the steps, parameters, and team responsibilities for
More informationKimberly S. New RN BSN JD Compliance Specialist University of Tennessee Medical Center
1 Institutional Drug Diversion Kimberly S. New RN BSN JD Compliance Specialist University of Tennessee Medical Center AHIA 31 st Annual Conference August 26-29, 2012 Philadelphia PA www.ahia.org Discussion
More informationMINNESOTA. Downloaded January 2011
MINNESOTA Downloaded January 2011 4658.1300 MEDICATIONS AND PHARMACY SERVICES; DEFINITIONS. Subpart 1. Controlled substances. "Controlled substances" has the meaning given in Minnesota Statutes, section
More informationMedicine Management Policy
INDEX Prescribing Page 2 Dispensing Page 3 Safe Administration Page 4 Problems & Errors Page 5 Self Administration Page 7 Safe Storage Page 8 Controlled Drugs Best Practice Procedure Page 9 Controlled
More informationOREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS
OREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS DIVISION 121 PHARMACEUTICAL SERVICES Non-Medicaid Rules Prescription Drug Monitoring Program 410-121-4000 Purpose The purpose of the Prescription
More informationMedication Assisted Treatment for Opioid Use Disorders Reporting Requirements
This document is scheduled to be published in the Federal Register on 09/27/2016 and available online at https://federalregister.gov/d/2016-23277, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES
More informationGENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 SESSION LAW SENATE BILL 750
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 SESSION LAW 2018-76 SENATE BILL 750 AN ACT TO ADDRESS HEALTH ISSUES IN LOCAL CONFINEMENT FACILITIES AND TO ENSURE THAT STATE PRISONS ARE FULL PARTICIPANTS
More information3/9/2010. Objectives. Pharmacist Role in Medication Safety and Regulatory Compliance
Pharmacist Role in Medication Safety and Regulatory Compliance Janet Greiwe Vice President, Systems Management Cleveland County Health System Objectives By the end of this presentation, you should be able
More informationOptimizing Medication Safety in Maryland Assisted Living Facilities. Panel Discussion Moderated by: Nicole Brandt, PharmD
Optimizing Medication Safety in Maryland Assisted Living Facilities Panel Discussion Moderated by: Nicole Brandt, PharmD 11 Objectives At the end of this knowledge based activity, the participants should
More informationDrug Diversion Exercise. New Jersey Department of Health Pilot Project-Safe Injection Practices January/February 2016
Drug Diversion Exercise New Jersey Department of Health Pilot Project-Safe Injection Practices January/February 2016 What is Drug Diversion When prescription medicines are obtained or used illegally This
More informationInstyMeds Prescription Writer Tutorial
InstyMeds Prescription Writer Tutorial July 2014 Log in to the InstyMeds Prescription Writer tool Important messages announcing the latest enhancements and notifications are located here. 1. Type in Username
More informationDOD INSTRUCTION DRUG TAKE BACK PROGRAM
DOD INSTRUCTION 6025.25 DRUG TAKE BACK PROGRAM Originating Component: Office of the Under Secretary of Defense for Personnel and Readiness Effective: April 26, 2016 Releasability: Approved by: Cleared
More informationTeaching Institution Application for Registration (Form DHHS 224-C)
Teaching Institution Application for Registration (Form DHHS 224-C) NC Department of Health and Human Services Division of Mental Health, Developmental Disabilities, and Substance Abuse Services Drug Control
More informationPharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A.
Pharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A. Objectives: Pharmacist and Pharmacy Technician Learning Objectives: At the end of this activity, participants
More informationTexas Administrative Code
RULE 19.1501 Pharmacy Services A licensed-only facility must assist the resident in obtaining routine drugs and biologicals and make emergency drugs readily available, or obtain them under an agreement
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) New York State Information contained in this presentation is accurate as of September 2017 Meet the Speaker Anita Murray, R.Ph., Deputy Director Bureau of Narcotic
More informationMedicare Advantage and Part D Fraud, Waste and Abuse Compliance Training 2015
Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training 2015 Overview This Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training for first-tier, downstream and related
More informationNORTH CAROLINA. Downloaded January 2011
NORTH CAROLINA Downloaded January 2011 10A NCAC 13D.2306 MEDICATION ADMINISTRATION (a) The facility shall ensure that medications are administered in accordance with standards of professional practice
More information5. returning the medication container to proper secured storage; and
111-8-63-.20 Medications. (1) Self-Administration of Medications. Residents who have the cognitive and functional capacities to engage in the self-administration of medications safely and independently
More informationCHAPTER 17 PHARMACEUTICAL SERVICES
17.A. Pharmaceutical Services Pharmaceutical services shall be conducted in accordance with currently accepted professional standards of practice and in accordance with all applicable laws and regulations.
More informationOklahoma. Contact Information. Office: Fax: Statistics
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vogt, Don - PMP Program Manager 419 NE 38th Terrace Oklahoma City OK 73105 Office: (405) 530-3140 Fax: (405) 524-7619 Email: dvogt@obn.state.ok.us
More informationSafety in the Pharmacy
Safety in the Pharmacy Course Practicum in Health Science - Pharmacology Unit I Preparation for Practicum Essential Question Why is safety in the pharmacy important not only to the patient, but the pharmacy
More informationHealthcare Workplace Violence PREVENTION: The California Experience. Gail M. Blanchard-Saiger VP, Labor & Employment California Hospital Association
Healthcare Workplace Violence PREVENTION: The California Experience Gail M. Blanchard-Saiger VP, Labor & Employment California Hospital Association Current Status Cal/OSHA is developing formal, comprehensive
More informationSession 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER
Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Disclosure The Immunization Action Coalition has been responsible for all aspects of content development for the enclosed presentation
More informationSession 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER
Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Disclosure The Immunization Action Coalition has been responsible for all aspects of content development for the enclosed presentation
More informationSubmitted electronically via: May 20, 2015
Submitted electronically via: http://www.regulations.gov May 20, 2015 Jane Axelrad, JD Associate Director for Policy, CDER Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers
More informationThank you for coming to our San Antonio Workshop THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER
Thank you for coming to our San Antonio Workshop THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Disclosure The
More informationRegulatory Agencies Impact on Health System Pharmacies
Regulatory Agencies Impact on Health System Pharmacies Winter 2006 Beverly Sheridan, RPh, JD Assistant Director, Harborview Pharmacy Affiliate Associate Professor, UW School of Pharmacy rower@u.washington.edu
More informationHordle CE (VA) Primary School and Nursery
Hordle CE (VA) Primary School and Nursery ADMINISTRATION OF MEDICINES POLICY Headteacher approving this policy - Fiona Adams.. Signature of Headteacher October 2015 Date Chair of Governors approving this
More informationSouth Carolina Compliance Update
South Carolina Compliance Update 2017 ACC Annual Meeting James Jamey Goldin and Robyn W. Madden November 7, 2017 Protecting the Public Increased focus to protect the public across the boards. South Carolina
More informationUnderstanding Diversion
Drug Diversion Prevention, Detection and Response Programs: Essential Knowledge for the Healthcare Professional John Burke, President, IHFDA Kimberly New, Executive Director, IHFDA 2016 All Rights Reserved
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) New Jersey Information contained in this presentation is accurate as of September 2017 Meet the Speaker Sindy Paul, MD, MPH, FACPM Medical Director - NJ Board
More informationPrivate Controlled Drugs Prescribing Self-Assessment
Private Controlled Drugs Prescribing Self-Assessment This self-assessment must be completed prior to issue of: - FP10PCD Private Controlled Drug Prescription forms Please complete ALL relevant parts of
More informationPOLICIES AND PROCEDURES. Pharmacy Services for Nursing Facilities
POLICIES AND PROCEDURES Pharmacy Services for Nursing Facilities Contents I. GENERAL POLICIES AND PROCEDURES A. Organizational Aspects 1. Provider Pharmacy Requirements... 1 2. Consultant Pharmacist Services
More informationRULES OF THE TENNESSEE BOARD OF NURSING CHAPTER ADVANCED PRACTICE NURSES & CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES & CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions
More informationDistrict of Columbia Prescription Drug Monitoring Program
District of Columbia Prescription Drug Monitoring Program What Our Users Need to Know Health Regulation and Licensing Administration Pharmaceutical Control Division February 28, 2017 1 Mission Statement
More informationCARE FACILITIES PART 300 SKILLED NURSING AND INTERMEDIATE CARE FACILITIES CODE SECTION MEDICATION POLICIES AND PROCEDURES
TITLE 77: PUBLIC HEALTH CHAPTER I: DEPARTMENT OF PUBLIC HEALTH SUBCHAPTER c: LONG-TERM CARE FACILITIES PART 300 SKILLED NURSING AND INTERMEDIATE CARE FACILITIES CODE SECTION 300.1610 MEDICATION POLICIES
More informationORGANIZATION OF AMERICAN STATES
ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION GROUP OF EXPERTS ON PHARMACEUTICAL PRODUCTS Guide for health professionals concerning counterfeit drugs Bahamas - Brasil Lima,
More informationIntegrating Opiate Agonist Treatment in Primary Care and Mental Health Settings: a clinical model
Integrating Opiate Agonist Treatment in Primary Care and Mental Health Settings: a clinical model Matt Tierney, NP Director, Office based Buprenorphine Induction Clinic (OBIC) UCSF & San Francisco Department
More informationPharmaceutical Services Requirements: formerly 10D and 10C.7
Pharmaceutical Services Requirements: formerly 10D.28-29 and 10C.7 Frank S. Emanuel, Pharm.D., FASHP Associate Professor/Division Director Florida A and M University College of Pharmacy Jacksonville Disclosure
More informationMedication Management Policy and Procedures
POLICY STATEMENT This policy establishes guidelines for ensuring safe and correct management of client medications in accordance with legislative and regulatory requirements and professional practice competency
More information38 May June 2014 OI
38 www.accc-cancer.org May June 2014 OI BY MICHAEL J. REFF, RPH, MBA Physician Dispensing Adding value to patients and the practice While oral oncolytics are serious medications prescribed to help patients
More informationRULES OF TENNESSEE DEPARTMENT OF LABOR AND WORKFORCE DEVELOPMENT WORKERS COMPENSATION DIVISION
RULES OF TENNESSEE DEPARTMENT OF LABOR AND WORKFORCE DEVELOPMENT WORKERS COMPENSATION DIVISION CHAPTER 0800-02-25 WORKERS COMPENSATION MEDICAL TREATMENT TABLE OF CONTENTS 0800-02-25-.01 Purpose and Scope
More informationObjectives. Institutional Pharmacy Practice. Medicare, Medicaid, What s the difference? Medicare Modernization Act
Objectives Institutional Pharmacy Practice Donald H. Williams, RPh, FASHP Affiliate Professor University of Washington To discuss the regulation of institutional pharmacy practice in Washington To differentiate
More informationApplicable State Licensing Requirements for Combined Federal and Comprehensive HHA Survey
Applicable State Licensing Requirements for Combined Federal and Comprehensive HHA Survey Statute 144A.44 HOME CARE BILL OF RIGHTS Subdivision 1. Statement of rights. A person who receives home care services
More informationRISK EVALUATION AND MITIGATION STRATEGY (REMS)
Initial REMS approval: XX/XXXX NDA 21338 IONSYS (fentanyl iontophoretic transdermal system) I. GOAL Fentanyl/Opioid The Medicines Company 8 Sylvan Way, Parsippany NJ 07054 Phone: 973-290-6050 RISK EVALUATION
More informationDisclosures. Learning Objectives. Pharmacy Law Topics. Spring Seminar 2017
Spring Seminar 2017 prescribing authority Controlled substance Privacy Pharmacy Law Topics Charlie Mollien, PharmD, JD, MS Director of Pharmacy Compliance & Privacy Officer Meijer Disclosures Charlie Mollien
More informationHealthcare Effectiveness Data and Information Set (HEDIS)
Healthcare Effectiveness Data and Information Set (HEDIS) IlliniCare Health is a proud holder of NCQA accreditation as a managed behavioral health organization (MBHO) and prioritizes best in class performance
More information9/15/2017. Nursing: Substance Use, Drug Diversion, and Recovery Nancy Rogers, MS, RN-BC, CASAC, CNE. Objectives. Substance Use Among Nurses
Nursing: Substance Use, Drug Diversion, and Recovery Nancy Rogers, MS, RN-BC, CASAC, CNE Objectives Participants will be able to discuss the warning signs of an impaired nurse Participants will be able
More informationNational Association of Boards of Pharmacy PMP Interconnect NABP
National Association of Boards of Pharmacy PMP Interconnect NABP Problems with PMPs: Persons engaging in doctor shopping don t stay in one state, particularly areas that border other states Querying the
More informationMissouri Board Of Pharmacy
Missouri Board Of Pharmacy 2014 Legislative/Rule Update Kim Grinston, J.D. Executive Director Objectives Discuss Missouri pharmacy law. Identify regulatory changes and initiatives related to Missouri law.
More informationDC Board of Pharmacy and Pharmaceutical Control Update
DC Board of Pharmacy and Pharmaceutical Control Update Patricia M. D Antonio, RPh, MS, MBA,CGP Executive Director, Board of Pharmacy Program Manager, Pharmaceutical Control May 30, 2015 Organization Health
More informationUnderstanding the Pharmacy and Drug Act amendments and mail order pharmacy licensing
Understanding the Pharmacy and Drug Act amendments and mail order pharmacy licensing Background As reported in the Spring 2009 issue of acpnews, ACP and Alberta Health and Wellness developed a new policy
More informationDRUG DIVERSION PREVENTION
DRUG DIVERSION PREVENTION in Healthcare Kimberly New, BSN, JD, RN Drug Diversion in Healthcare Kimberly New, BSN, JD, RN Drug Diversion in Healthcare is published by HCPro, a division of BLR. Copyright
More informationPOSITION STATEMENT. - desires to protect the public from students who are chemically impaired.
Page 1 of 18 POSITION STATEMENT The School of Pharmacy and Health Professions: - desires to protect the public from students who are chemically impaired. - recognizes that chemical impairment (including
More information2017 ASHP Proposed Policies: To Approve or Not to Approve, That is the Question. Disclosures. Learning Objectives 3/16/2017
2017 ASHP Proposed Policies: To Approve or Not to Approve, That is the Question Nicole Allcock, PharmD, BCPS, FASHP Noelle RM Chapman, PharmD, BCPS, FASHP Joel Hennenfent, PharmD, MBA, BCPS, FASHP Jen
More informationTHE TEXAS GUIDE TO SCHOOL HEALTH PROGRAMS 251
THE TEXAS GUIDE TO SCHOOL HEALTH PROGRAMS 251 Exhibit 1: Skills Checklist for Medication Administration Person trained: Position: Instructor: Type of Medication Administration (Oral, Topical etc.): (*See
More informationDefinitions: In this chapter, unless the context or subject matter otherwise requires:
CHAPTER 61-02-01 Final Copy PHARMACY PERMITS Section 61-02-01-01 Permit Required 61-02-01-02 Application for Permit 61-02-01-03 Pharmaceutical Compounding Standards 61-02-01-04 Permit Not Transferable
More informationTemplate (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment
Template (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment The PRN Purpose & Outcome Protocol (PRN POP) Background The term PRN (from
More informationDelegator Dashboard User Guide
Delegator Dashboard User Guide ULP Delegator Dashboard Technical Guide This guide is intended for a Prescriber or Pharmacist who is utilizing Delegates to facilitate PDMP data access. A separate guide
More informationEnsuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING
Ensuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING Contents Page 1.0 Purpose 2 2.0 Definition of medication error
More informationPREPARATION AND ADMINISTRATION
LESSON PLAN: 12 COURSE TITLE: UNIT: IV MEDICATION TECHNICIAN PREPARATION AND ADMINISTRATION SCOPE OF UNIT: Guidelines and procedures for preparation, administration, reporting, and recording of oral, ophthalmic,
More informationS. ll. To amend the Controlled Substances Act with respect to the provision of emergency medical services. IN THE SENATE OF THE UNITED STATES A BILL
TH CONGRESS D SESSION S. ll To amend the Controlled Substances Act with respect to the provision of emergency medical services. IN THE SENATE OF THE UNITED STATES llllllllll Mr. CASSIDY introduced the
More informationPrescribing Standards for Nurse Practitioners (NPs)
Standards Prescribing Standards for Nurse Practitioners (NPs) Month Year PRESCRIBING FOR NURSE PRACTITIONERS MONTH YEAR i Approved by the College and Association of Registered Nurses of Alberta () Provincial
More informationNATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT
1 NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) SECTION 1. SHORT TITLE. This Act shall be known and may be cited as the
More informationInternational Pharmaceutical Federation Fédération internationale pharmaceutique. Standards for Quality of Pharmacy Services
International Pharmaceutical Federation Fédération internationale pharmaceutique PO Box 84200, 2508 AE The Hague, The Netherlands Standards for Quality of Pharmacy Services Standards are an important part
More informationIf viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.
If viewing a printed copy of this policy, please note it could be expired. Got to www.fairview.org/fhipolicies to view current policies. Department Policy Entity: Fairview Pharmacy Services Department:
More information